New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
SELLAS Life Sciences Group, Inc.
SLS
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

79M

Biotechnology

Next Earning date - 14 Nov 2024

79M

Biotechnology

Next Earning date - 14 Nov 2024

1.23USD
Shape0.13 ( 11.82%)
favorite-chart

Relative Strenght

87
favorite-chart

Volume Buzz

60%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

28%

Quote Panel

Shape
Updated October 27, 2024
1W 3.36 % 1M -1.60 % 3M 0.82 % 1Y 6.03 %

Key Metrics

Shape
  • Market Cap

    79.13M


  • Shares Outstanding

    64.33M


  • Share in Float

    64.06M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    1.23


  • Average Volume

    593321


  • Beta

    2.392


  • Range

    0.5-1.72


  • Industry

    Biotechnology


  • Website

    https://www.sellaslifesciences.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

24.33x

P/B Ratio

0.2

Debt/Equity

0.0%

Net Margin

$-0.9

EPS

How SLS compares to sector?

P/E Ratio

Relative Strength

Shape

SLS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$32M

ShapeNaN%

2025-Revenue

$0.46

Shape-254%

2025-EPS

$6M

Shape16%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.34
vs -0.45

Q4.22

arrow
arrow

N/A

-0.43
vs -0.42

Q1.23

arrow
arrow

N/A

-0.47
vs -1.05

Q2.23

arrow
arrow

N/A

-0.31
vs -0.41

Q3.23

arrow
arrow

N/A

-0.33
vs -0.34

Q4.23

arrow
arrow

N/A

-0.25
vs -0.43

Q1.24

arrow
arrow

N/A

-0.21
vs -0.47

Q2.24

arrow
arrow

N/A

-0.13
vs -0.31

Q3.24

arrow
arrow

N/A

-0.13
vs -0.33

Q4.24

arrow
arrow

N/A

-0.12
vs -0.25

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

-82%

1M  vs 5.7M

Q2.22

arrow
arrow

-100%

NA  vs 1.9M

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

+87%

-1000000.00  vs -7600000

Q1.23

arrow
arrow

-100%

NA  vs 1M

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

+100%

NA  vs -1000000

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-54%

-0.54
vs -0.43

Q4.22

arrow
arrow

-177%

-1.77
vs -0.54

Q1.23

arrow
arrow

-83%

-0.83
vs -1.77

Q2.23

arrow
arrow

-183%

-1.83
vs -0.83

Q3.23

arrow
arrow

+242%

2.42
vs -1.83

Q4.23

arrow
arrow

+102%

1.02
vs 2.42

Q1.24

arrow
arrow

-99%

-0.99
vs 1.02

Q2.24

arrow
arrow

-256%

-2.56
vs -0.99

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

31

31
vs 29

7%

Q4.22

arrow
arrow

31

31
vs 31

NA

Q1.23

arrow
arrow

27

27
vs 31

-13%

Q2.23

arrow
arrow

26

26
vs 27

-4%

Q3.23

arrow
arrow

29

29
vs 26

12%

Q4.23

arrow
arrow

33

33
vs 29

14%

Q1.24

arrow
arrow

33

33
vs 33

NA

Q2.24

arrow
arrow

35

35
vs 33

6%

Earnings Growth

Latest News